<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE Limited information is available regarding the metabolic <z:e sem="disease" ids="C1384955,C0002351" disease_type="Disease or Syndrome;Injury or Poisoning" abbrv="">effects of high altitude</z:e> trekking in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS Thirteen individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> took part in a 12-day expedition to the summit of Mount Toubkal (altitude, 4,167 m), Morocco, after 6 months of exercise training </plain></SENT>
<SENT sid="2" pm="."><plain>Energy expenditure, body weight, blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, fasting insulin, <z:chebi fb="23" ids="18059">lipids</z:chebi>, and HbA(1c) were assessed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS Training reduced fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (-0.7 ± 0.9 mmol/L, P = 0.026) and increased exercise capacity (+0.3 ± 0.3 W/kg, P = 0.005) </plain></SENT>
<SENT sid="4" pm="."><plain>High altitude trekking decreased fasting insulin concentrations (-3.8 ± 3.2 μU/L, P = 0.04), total cholesterol (-0.7 ± 0.8 mmol/L, P = 0.008), and <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> (-0.5 ± 0.6 mmol/L, P = 0.007) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS High altitude trekking preceded by exercise training is feasible for patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>It improves blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:chebi fb="23" ids="18059">lipids</z:chebi>, and fasting insulin concentrations, while <z:chebi fb="105" ids="17234">glucose</z:chebi> control is maintained </plain></SENT>
</text></document>